Fourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial Suggests
A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial in Israel released Monday. Bloomberg reports: Two weeks after the start of the trial of 154 medical personnel at the Sheba Medical Center in Tel Read more…






